26-11-2025 /

AB-CT appoints Natalie Erdmann as CMO and Board Member

Natalie Erdmann has been appointed Chief Marketing Officer and Member of the Board. After contributing in this role externally since February 2025, she has now formally joined the leadership team.

Natalie brings more than two decades of experience in shaping visibility, trust and growth in healthcare, medical technology and AI. She is known for her strategic thinking, her vibrant energy and her ability to turn complex innovation into strong market relevance. While continuing her work with her company Synwisery — allowing the wider ecosystem to benefit from her expertise — she will take on a central role in strengthening AB-CT’s mission and presence.

AB-CT’s CEO Bernd Schleicher comments: “Natalie has an exceptional talent for connecting technology, people, and purpose. She understands how to position innovation in a way that really moves markets and minds. Her perspective and clarity add exactly the dimension we want at the table as we drive the next evolution of breast imaging.”

Natalie Erdmann adds: “What convinced me about AB-CT is the outstanding mix of scientific rigor, engineering vision, and a genuine ambition to improve women’s health. I am looking forward to ensuring that this technology finds the place in clinical practice worldwide. The team here is incredibly smart, accomplished, and still down-to-earth — great people to work with!”

With Natalie joining the Board alongside Bernd Schleicher (CEO), Dr. Daniel Kolditz (CTO), Dr. Felix Althoff (CINO), Oliver Dietrich (CSO), and Frank P. (Head of Finance), we are strengthening the strategic foundation that will guide AB-CT through its next phase of global growth.